BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Wu HP, Feng GS, Liang HM, Zheng CS, Li X. Vascular endothelial growth factor antisense oligodeoxynucleotides with lipiodol in arterial embolization of liver cancer in rats. World J Gastroenterol 2004; 10(6): 813-818 [PMID: 15040023 DOI: 10.3748/wjg.v10.i6.813]
URL: https://www.wjgnet.com/1007-9327/full/v10/i6/813.htm
Number Citing Articles
1
Yongjie Huang, Tiansi Wang, Jiefen Yang, Xin Wu, Wei Fan, Jianming Chen. Current Strategies for the Treatment of Hepatocellular Carcinoma by Modulating the Tumor Microenvironment via Nano-Delivery Systems: A ReviewInternational Journal of Nanomedicine 2022; : 2335 doi: 10.2147/IJN.S363456
2
Bao T. Le, Prithi Raguraman, Tamer R. Kosbar, Susan Fletcher, Steve D. Wilton, Rakesh N. Veedu. Antisense Oligonucleotides Targeting Angiogenic Factors as Potential Cancer TherapeuticsMolecular Therapy - Nucleic Acids 2019; 14: 142 doi: 10.1016/j.omtn.2018.11.007
3
Sun Hwa Kim, Soo Hyeon Lee, Huayu Tian, Xuesi Chen, Tae Gwan Park. Prostate cancer cell–specific VEGF siRNA delivery system using cell targeting peptide conjugated polyplexesJournal of Drug Targeting 2009; 17(4): 311 doi: 10.1080/10611860902767232
4
Hongxin Cai, Xiaoyue Du, Yufeng Deng, Dejian Cao, Lele Wang, Zhiguo Wu, Xianchao Zhang, Jinbiao Xu, Baogang Xie. Pharmacokinetics and apparent Michaelis constant for metabolite conversion of sorafenib in healthy and hepatocellular carcinoma-bearing ratsBioanalysis 2024; 16(10): 461 doi: 10.4155/bio-2023-0215
5
David Semela, Jean-François Dufour. Signaling Pathways in Liver Diseases2010; : 421 doi: 10.1007/978-3-642-00150-5_28
6
Roberta Pang, Ronnie T.P. Poon. Angiogenesis and antiangiogenic therapy in hepatocellular carcinomaCancer Letters 2006; 242(2): 151 doi: 10.1016/j.canlet.2006.01.008
7
David Semela, Jean-François Dufour. Angiogenesis and hepatocellular carcinomaJournal of Hepatology 2004; 41(5): 864 doi: 10.1016/j.jhep.2004.09.006
8
Ching-Chiu Liu, Zan Shen, Hsiang-Fu Kung, Marie CM Lin. Cancer gene therapy targeting angiogenesis: An updated ReviewWorld Journal of Gastroenterology 2006; 12(43): 6941-6948 doi: 10.3748/wjg.v12.i43.6941
9
SABINE KRAUSE, YVONNE FÖRSTER, KAI KRAEMER, SUSANNE FUESSEL, MATTHIAS KOTZSCH, UTA SCHMIDT, MANFRED P. WIRTH, AXEL MEYE, BERND SCHWENZER. VASCULAR ENDOTHELIAL GROWTH FACTOR ANTISENSE PRETREATMENT OF BLADDER CANCER CELLS SIGNIFICANTLY ENHANCES THE CYTOTOXICITY OF MITOMYCIN C, GEMCITABINE AND CISPLATINJournal of Urology 2005; 174(1): 328 doi: 10.1097/01.ju.0000161588.94827.27
10
E. Jubeli, N. Yagoubi, F. Pascale, L. Bédouet, K. Slimani, D. Labarre, J.P. Saint-Maurice, A. Laurent, L. Moine. Embolization biomaterial reinforced with nanotechnology for an in-situ release of anti-angiogenic agent in the treatment of hyper-vascularized tumors and arteriovenous malformationsEuropean Journal of Pharmaceutics and Biopharmaceutics 2015; 96: 396 doi: 10.1016/j.ejpb.2015.09.006
11
David Semela, Jean-François Dufour. Signaling Pathways in Liver Diseases2005; : 91 doi: 10.1007/3-540-27194-5_8
12
Anand C. Annan, Paul B. Fisher, Paul Dent, Gene P. Siegal, David T. Curiel. The Molecular Basis of Human Cancer2017; : 811 doi: 10.1007/978-1-59745-458-2_42
13
Md. Emranul Karim, Kyi Kyi Tha, Iekhsan Othman, Mohammad Borhan Uddin, Ezharul Hoque Chowdhury. Therapeutic Potency of Nanoformulations of siRNAs and shRNAs in Animal Models of CancersPharmaceutics 2018; 10(2): 65 doi: 10.3390/pharmaceutics10020065
14
Junning Zhang, Dinglu Peng, Wei Qin, Weizhi Qi, Xiaoya Liu, Yucheng Luo, Qiongyu Guo, Lei Xi. Organ‐PAM: Photoacoustic Microscopy of Whole‐organ Multiset Vessel SystemsLaser & Photonics Reviews 2023; 17(7) doi: 10.1002/lpor.202201031
15
Xinting Pan, Weihua Sheng, Qingyun Zhu, Yufeng Xie, Zhenmin Ye, Jim Xiang, Dechun Li, Jicheng Yang. Inhibition of Pancreatic Carcinoma Growth by Adenovirus-Mediated Human Interleukin-24 Expression in Animal ModelCancer Biotherapy and Radiopharmaceuticals 2008; 23(4): 425 doi: 10.1089/cbr.2008.0461
16
Xiong‐Zhi Wu, Guang‐Ru Xie, Dan Chen. Hypoxia and hepatocellular carcinoma: The therapeutic target for hepatocellular carcinomaJournal of Gastroenterology and Hepatology 2007; 22(8): 1178 doi: 10.1111/j.1440-1746.2007.04997.x
17
Bin Liang, ChuanSheng Zheng, GanSheng Feng, HanPing Wu, Yong Wang, Hui Zhao, Xin Li, Jun Qian, HuiMin Liang. Experimental Evaluation of Inhibitory Effect of 10-Hydroxycamptothecin on Hypoxia-inducible Factor-1α Expression and Angiogenesis in Liver Tumors after Transcatheter Arterial EmbolizationJournal of Vascular and Interventional Radiology 2010; 21(10): 1565 doi: 10.1016/j.jvir.2010.05.028
18
Bio-Targets and Drug Delivery Approaches2016; : 297 doi: 10.1201/9781315370118-13
19
Ron C. Gaba, Regina M. Schwind, Sebastien Ballet. Mechanism of Action, Pharmacokinetics, Efficacy, and Safety of Transarterial Therapies Using Ethiodized Oil: Preclinical Review in Liver Cancer ModelsJournal of Vascular and Interventional Radiology 2018; 29(3): 413 doi: 10.1016/j.jvir.2017.09.025
20
Sun Hwa Kim, Ji Hoon Jeong, Soo Hyeon Lee, Sung Wan Kim, Tae Gwan Park. Local and systemic delivery of VEGF siRNA using polyelectrolyte complex micelles for effective treatment of cancerJournal of Controlled Release 2008; 129(2): 107 doi: 10.1016/j.jconrel.2008.03.008
21
Zhen Fan Yang, Ronnie T.P. Poon. Vascular Changes in Hepatocellular CarcinomaThe Anatomical Record 2008; 291(6): 721 doi: 10.1002/ar.20668
22
Young Il Kim, Jin Wook Chung. Selective or targeted gene/drug delivery for liver tumors: advantages and current status of local deliveryExpert Review of Gastroenterology & Hepatology 2008; 2(6): 791 doi: 10.1586/17474124.2.6.791
23
Zhenmin Ye, Xiaohua Wang, Siguo Hao, Jiang Zhong, Jim Xiang, Jicheng Yang. Oncolytic Adenovirus-Mediated E1A Gene Therapy Induces Tumor-Cell Apoptosis and Reduces Tumor Angiogenesis Leading to Inhibition of Hepatocellular Carcinoma Growth in Animal ModelCancer Biotherapy and Radiopharmaceuticals 2006; 21(3): 225 doi: 10.1089/cbr.2006.21.225
24
Gang Deng, Deng-Ling Zhao, Guang-Chao Li, Hui Yu, Gao-Jun Teng. Combination Therapy of Transcatheter Arterial Chemoembolization and Arterial Administration of Antiangiogenesis on VX2 Liver TumorCardioVascular and Interventional Radiology 2011; 34(4): 824 doi: 10.1007/s00270-011-0179-x